Th1-derived cytokine IFN-γ is a potent inhibitor of eotaxin synthesis in vitro

被引:42
作者
Miyamasu, M
Yamaguchi, M
Nakajima, T
Misaki, Y
Morita, Y
Matsushima, K
Yamamoto, K
Hirai, K
机构
[1] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Bioregulatory Funct, Bunkyo Ku, Tokyo 1138655, Japan
[3] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 1138655, Japan
[4] Univ Tokyo, Grad Sch Med, CREST, Bunkyo Ku, Tokyo 1138655, Japan
关键词
allergy; ELlSA; eosinophil; fibroblast; IL-4;
D O I
10.1093/intimm/11.6.1001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Eotaxin potentially plays an integral role in tissue eosinophilia. Inasmuch as T(h)2-derived cytokine IL-4 has been shown to stimulate eotaxin generation, we investigated here the effect of Th1-derived cytokine IFN-gamma On human eotaxin production. IFNr but not -alpha or -beta potently inhibited tumor necrosis factor (TNF)-alpha-induced eotaxin generation by dermal fibroblasts. The inhibitory effect was unique to eotaxin, because production of IL-8 or monocyte chemoattractant protein (MCP)-1 protein was not affected by the treatment with IFN-gamma. Furthermore, the suppressive effect of IFNr was not cell-type or stimulus specific, The level of eotaxin mRNA increased within 2 h after activation with TNF-alpha and continued to increase up to 72 h, IFN-gamma did not inhibit, but rather augmented the TNF-a-induced accumulation of mRNA in the early phase (similar to 6 h), However, in the later phase, IFNr completely prevented the subsequent elevation of eotaxin mRNA and sustained it at low levels. Although the protective effect of IFNr against allergic inflammation has been assumed to result from its sole regulation of the proliferation of T(h)2-type T lymphocytes, these results imply that IFNr can also directly act on stromal cells to inhibit eotaxin production and consequently intervene in eosinophil recruitment.
引用
收藏
页码:1001 / 1004
页数:4
相关论文
共 19 条
  • [1] Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia
    GarciaZepeda, EA
    Rothenberg, ME
    Ownbey, RT
    Celestin, J
    Leder, P
    Luster, AD
    [J]. NATURE MEDICINE, 1996, 2 (04) : 449 - 456
  • [2] Chemokine receptor usage by human eosinophils - The importance of CCR3 demonstrated using an antagonistic monoclonal antibody
    Heath, H
    Qin, SX
    Rao, P
    Wu, LJ
    LaRosa, G
    Kassam, N
    Ponath, PD
    Mackay, CR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (02) : 178 - 184
  • [3] Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene
    Hein, H
    Schluter, C
    Kulke, R
    Christophers, E
    Schroder, JM
    Bartels, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 237 (03) : 537 - 542
  • [4] INTERFERON-GAMMA REGULATES ANTIGEN-INDUCED EOSINOPHIL RECRUITMENT INTO THE MOUSE AIRWAYS BY INHIBITING THE INFILTRATION OF CD4+ T-CELLS
    IWAMOTO, I
    NAKAJIMA, H
    ENDO, H
    YOSHIDA, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) : 573 - 576
  • [5] Expression and regulation of monocyte chemoattractant protein-1 by human eosinophils
    Izumi, S
    Hirai, K
    Miyamasu, M
    Takahashi, Y
    Misaki, Y
    Takaishi, T
    Morita, Y
    Matsushima, K
    Ida, N
    Nakamura, H
    Kasahara, T
    Ito, K
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (04) : 816 - 824
  • [6] EOTAXIN - A POTENT EOSINOPHIL CHEMOATTRACTANT CYTOKINE DETECTED IN A GUINEA-PIG MODEL OF ALLERGIC AIRWAYS INFLAMMATION
    JOSE, PJ
    GRIFFITHSJOHNSON, DA
    COLLINS, PD
    WALSH, DT
    MOQBEL, R
    TOTTY, NF
    TRUONG, O
    HSUAN, JJ
    WILLIAMS, TJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) : 881 - 887
  • [7] MECHANISMS OF ALLERGIC PULMONARY EOSINOPHILIA IN THE MOUSE
    KUNG, TT
    STELTS, D
    ZURCHER, JA
    WATNICK, AS
    JONES, H
    MAUSER, PJ
    FERNANDEZ, X
    UMLAND, S
    KREUTNER, W
    CHAPMAN, RW
    EGAN, RW
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 94 (06) : 1217 - 1224
  • [8] Glucocorticoids inhibit chemokine generation by human eosinophils
    Miyamasu, M
    Misaki, Y
    Izumi, S
    Takaishi, T
    Morita, Y
    Nakamura, H
    Matsushima, K
    Kasahara, T
    Hirai, K
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : 75 - 83
  • [9] MIYAMASU M, 1995, J IMMUNOL, V154, P1339
  • [10] Mochizuki M, 1998, J IMMUNOL, V160, P60